US approves Regeneron antibody treatment given to Trump

WASHINGTON — A Covid-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren’t yet hospitalized by the disease but are at high risk.

The green light for drugmaker Regeneron came after REGEN-COV2, a combination of two lab-made antibodies, was shown to reduce Covid-19-related hospitalizations or emergency room visits in patients with underlying conditions.

“Authorizing these monoclonal antibody therapies may help outpatients avoid hospitalization and alleviate the burden on our health care system,” said Stephen Hahn, commissioner of the Food and Drug Administration (FDA).

Leonard Schleifer, Regeneron’s pr…

Keep on reading: US approves Regeneron antibody treatment given to Trump

Must Read

Rex Gatchalian hits NLEx for having ‘no concrete action plans’...

MANILA, Philippines --- Valenzuela Mayor Rex Gatchalian fumed at the North Luzon Expressway management on Saturday for "lack of concrete plans" to fix the...